| 0 (0%) | 04-19 00:52 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |  |
|||
| Targets | 6-month : | 13.91  |
1-year : | 14.19 |
| Resists | First : | 11.91 |
Second : | 12.14 |
| Pivot price | 11.81 |
|||
| Supports | First : | 11.52 | Second : | 9.59 |
| MAs | MA(5) : | 11.62 |
MA(20) : | 11.85 |
| MA(100) : | 11.8 |
MA(250) : | 11.4 |
|
| MACD | MACD : | -0.1 |
Signal : | -0.1 |
| %K %D | K(14,3) : | 13.9 |
D(3) : | 9.7 |
| RSI | RSI(14): 33.2 |
|||
| 52-week | High : | 12.21 | Low : | 9.68 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.[ NVG ] has closed above bottom band by 18.5%. Bollinger Bands are 17.7% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 11.66 - 11.73 | 11.73 - 11.79 |
| Low: | 11.44 - 11.52 | 11.52 - 11.58 |
| Close: | 11.5 - 11.62 | 11.62 - 11.73 |
Tue, 18 Mar 2014
Novagen, Inc. And CanTx Experimental Drug, Trx-1, Proves Effective In Vivo - BioSpace
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
|
|
|
Sector:
|
|
|
Industry:
|
|
| Shares Out | 214 (M) |
| Shares Float | 0 (M) |
| Held by Insiders | 0 (%) |
| Held by Institutions | 21.4 (%) |
| Shares Short | 41 (K) |
| Shares Short P.Month | 109 (K) |
| EPS | 0.12 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 11.78 |
| Profit Margin | 12.2 % |
| Operating Margin | 81 % |
| Return on Assets (ttm) | 2.4 % |
| Return on Equity (ttm) | 1 % |
| Qtrly Rev. Growth | -0.7 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 1.04 |
| EBITDA (p.s.) | 0 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 197 (M) |
| Levered Free Cash Flow | -1,160 (M) |
| PE Ratio | 89.3 |
| PEG Ratio | 0 |
| Price to Book value | 0.98 |
| Price to Sales | 11.14 |
| Price to Cash Flow | 12.6 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|